Back to Search
Start Over
Evaluation of platelet‐rich plasma plus basic fibroblast growth factor combined with minoxidil in the treatment of androgenetic alopecia: A randomized controlled trial.
- Source :
-
Journal of Cosmetic Dermatology . Jul2023, Vol. 22 Issue 7, p1995-2002. 8p. - Publication Year :
- 2023
-
Abstract
- Background: Platelet‐rich plasma plus basic fibroblast growth factor (PRPF) has been confirmed to be a safe and valuable therapy for androgenetic alopecia (AGA). However, the efficacy of PRPF combined with minoxidil treatment remains unknown. Objective: To assess the efficacy of combined PRPF and minoxidil treatment for AGA. Methods: In this prospective, randomized controlled trial, 75 patients with AGA were randomly divided into three groups and were administered the following treatments: Group 1, direct intradermal PRPF injection; Group 2, topical minoxidil 5% twice daily; and Group 3, PRPF injection combined with minoxidil. The PRPF injection was performed three times, 1 month apart. Hair growth parameters were evaluated using a trichoscope until the sixth month of the study. Patient satisfaction and side effects were recorded during the follow‐up. Results: All patients showed improvements (p < 0.05) in hair count, terminal hair, and decrease in telogen hair ratio after treatment. The efficacy of PRPF complex therapy revealed significant improvements (p < 0.05) in hair count, terminal hair and growth rate, compared with monotherapy. Limitations: Small sample size, short follow‐up time and lack of quantification of GFs in PRPF. Conclusion: The effect of complex therapy exceed both the effects of PRPF monotherapy and minoxidil treatment, which can be a beneficial AGA treatment strategy. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 14732130
- Volume :
- 22
- Issue :
- 7
- Database :
- Academic Search Index
- Journal :
- Journal of Cosmetic Dermatology
- Publication Type :
- Academic Journal
- Accession number :
- 164421224
- Full Text :
- https://doi.org/10.1111/jocd.15825